MURA Live signals | Maximize Profits with Getagraph.com

BUY 120327 min ago

@ $4.55

Issued: 14 Feb 2024 @ 12:08

Return: -15.82%

Previous signal: Feb 14 - 09:34

Previous signal: Sell

Return: -0.44 %

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 16:00):

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer...

Stats
Today's Volume	90 466.00
Average Volume	234 291
Market Cap	64.81M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $-2.66 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00500 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-14	Cuss Francis M	Buy	15 021	Stock Option (right to buy)
2023-12-14	Jackson Scott Thomas	Buy	15 021	Stock Option (right to buy)
2023-12-14	Hickey Benjamin	Buy	15 021	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	146 452	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	78 859	Ordinary Shares

INSIDER POWER
100.00
Last 10 transactions
Buy: 353 823 \| Sell: 0

Volume Correlation

Long: 0.09 (neutral)

Short: -0.86 (strong negative)

Signal:(49.865) Neutral

Mural Oncology plc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mural Oncology plc Correlation - Currency/Commodity

0.25
( neutral )

0.00
( neutral )

0.81
( strong )

Mural Oncology plc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2023
Revenue:	$0
Gross Profit:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-11.99

Financial Reports:

No articles found.

Mural Oncology plc

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.